Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,983.00    -0.50 (-0.03%)
Bid:
1,978.50
Ask:
1,979.50
Spread: 1.00 (0.051%)
Market Cap: £79.45b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

LONDON BRIEFING: Phoenix Group "ahead of plan"; AstraZeneca makes buy
17 Mar 2025

LONDON BRIEFING: Phoenix Group "ahead of plan"; AstraZeneca makes buy

(Alliance News) - Stocks in London are called to open flat on Monday, as investors digest plans by Chinese officials to boost consumption there, befor...

LONDON MARKET CLOSE: Global stocks knocked as trade war fears bite
4 Mar 2025

LONDON MARKET CLOSE: Global stocks knocked as trade war fears bite

(Alliance News) - Stocks fell sharply on Tuesday on concerns tit-for-tit moves on tariffs would spark a full-blown trade war.

GSK says US FDA accepts two depemokimab indication submissions
3 Mar 2025

GSK says US FDA accepts two depemokimab indication submissions

(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has accepted for review the biologics license application for depemokimab i...

FDA to review GSK's depemokimab
3 Mar 2025

FDA to review GSK's depemokimab

(Sharecast News) - Pharmaceutical giant GSK said on Monday that the US Food and Drug Administration has agreed to review its Biologics License Applica...

LONDON MARKET OPEN: Stocks rise, Hunting pleases with Rival sale
3 Mar 2025

LONDON MARKET OPEN: Stocks rise, Hunting pleases with Rival sale

(Alliance News) - Stock prices in London opened higher on Monday, ahead of the UK manufacturing PMI and following like releases from other regions.

GSK abandons diversity targets following Trump pressure
27 Feb 2025

GSK abandons diversity targets following Trump pressure

LONDON, Feb 27 (Reuters) - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale...

Sensodyne maker Haleon says 2025 revenue growth skewed to second half
27 Feb 2025

Sensodyne maker Haleon says 2025 revenue growth skewed to second half

2025 organic revenue expected to grow 4% to 6% *

LONDON MARKET OPEN: Stocks flat but EnergyPathways surges
24 Feb 2025

LONDON MARKET OPEN: Stocks flat but EnergyPathways surges

(Alliance News) - Stock prices in London opened mostly flat on Monday, while across the channel Germany's election results have sparked uncertainty bu...